AHNAK as a Prognosis Factor Suppresses the Tumor Progression in Glioma

Zijin Zhao(Central South University), Qing Liu(Central South University), Xiangyu Wang(Central South University), Chi Zhang(Northeast Agricultural University), Songhua Xiao(Sun Yat-sen University), Xianrui Yuan(Shandong Normal University), Jian Yuan(Tongji University), Jun Su(Central South University), Haoyu Li(Qingdao University)
Journal of Cancer
January 1, 2017
10.7150/jca.20277
Cited by 46

Related Papers

The Lysosomal v-ATPase-Ragulator Complex Is a Common Activator for AMPK and mTORC1, Acting as a Switch between Catabolism and Anabolism
|Cell Metabolism|2014|545
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial
|BMJ|2022|494
Metabolic regulation of homologous recombination repair by MRE11 lactylation
|Cell|2023|374
Merging of Kirkendall Growth and Ostwald Ripening: CuO@MnO2 Core-shell Architectures for Asymmetric Supercapacitors
|Scientific Reports|2014|279
Subwavelength-resolution label-free photoacoustic microscopy of optical absorption in vivo
|Optics Letters|2010|279